Company intelligence / Profile preview

Enable Innovations

Ownership: Private
Development stage: Commercial

Overview

Enable Innovations is an Italian CDMO specializing in the development, aseptic production, and packaging of sterile liquid products—primarily eye drops and nasal sprays—classified as substance-based medical devices. The company holds ISO 13485:2021 certification and has obtained CE marking under MDR for its eye drop line. It offers both contract manufacturing services and ready-to-market certified products.

Therapeutic areas: PulmonologyOphthalmologyOther
Modalities: Device
Industry: Contract Manufacturing Organization

Partnerships

No major pharmaceutical or biotech partnerships specifically named; collaborates with external laboratories for development activities.

Beyond the preview

Go deeper on Enable Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enable Innovations.

Explore the full profile